Fractionated cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (Snccl): A randomized trial of the pediatric oncology group

Medical and Pediatric Oncology

Volumn 29, Issue 6, 1997, Pages 526-533

  Brecher, M L ^a   Schwenn, M R ^a   Coppes, M J ^a   Bowman, W P ^a   Link, M P ^a   Berard, C W ^a   Shuster, J J ^a   Murphy, S B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Dose intensification; Fractionated cyclophosphamide; High dose methotrexate; Small non cleaved cell lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FOLINIC ACID; HYDROCORTISONE; METHOTREXATE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN TISSUE; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SURVIVAL; TREATMENT OUTCOME; UNDIFFERENTIATED LYMPHOMA; DRUG ADMINISTRATION; INFANT; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; PROSPECTIVE STUDY;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYTARABINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; LYMPHOMA, SMALL NONCLEAVED-CELL; MALE; METHOTREXATE; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0030610787     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199712)29:6<526::AID-MPO2>3.0.CO;2-M     Document Type: Article

References (18)